GSD — Devonian Health Income Statement
0.000.00%
Last trade - 00:00
- CA$32.61m
- CA$31.76m
- CA$2.35m
- 34
- 23
- 26
- 18
2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.94 | 2.14 | 1.47 | 2.31 | 2.35 |
Cost of Revenue | |||||
Gross Profit | 3.11 | -0.07 | -0.241 | 0.561 | 0.892 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9.66 | 6.65 | 4.82 | 5.75 | 6.95 |
Operating Profit | -3.72 | -4.5 | -3.35 | -3.45 | -4.6 |
Gain / Loss on Sale of Assets | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.22 | -4.37 | -3.35 | -3.45 | -4.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.98 | -4.37 | -3.35 | -3.45 | -4.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.98 | -4.37 | -3.35 | -3.45 | -4.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.98 | -4.37 | -3.35 | -3.45 | -4.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.048 | -0.062 | -0.038 | -0.029 | -0.034 |